Clinical Trial Update: Study to Assess the Safety, Tolerability, and Efficacy of Tipifarnib Plus Bortezomib in the Treatment of Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is described to evaluate the safety, tolerability, and efficacy of the combination of tipifarnib and bortezomib in acute myeloid leukem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Bortezomib (bortezomib)
• Tipifarnib (tipifarnib)

Snippet

Sponsor: University of Bologna | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: UNKNOWN